New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Nevro Corp.
NVRO
Shape
US Flag

NYSE

Unprofitable

Unprofitable

177M

Medical - Devices

Next Earning date - 11 Nov 2024

177M

Medical - Devices

Next Earning date - 11 Nov 2024

4.75USD
Shape-0.10 ( -2.06%)
Market Open
favorite-chart

Relative Strenght

1
favorite-chart

Volume Buzz

-86%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

79%

Quote Panel

Shape
Updated October 25, 2024
1W -9.58 % 1M -9.23 % 3M -51.54 % 1Y -68.84 %

Key Metrics

Shape
  • Market Cap

    177.10M


  • Shares Outstanding

    37.28M


  • Share in Float

    35.24M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    4.75


  • Average Volume

    618228


  • Beta

    0.937


  • Range

    4.382-22.64


  • Industry

    Medical - Devices


  • Website

    https://www.nevro.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.42x

P/S Ratio

0.65x

P/B Ratio

0.8

Debt/Equity

-18.2%

Net Margin

$-2.1

EPS

How NVRO compares to sector?

P/E Ratio

Relative Strength

Shape

NVRO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$412M

Shape295%

2025-Revenue

$2.57

Shape-385%

2025-EPS

$108M

Shape-425%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Citigroup

upgrade

Previous: Sell

2024-08-08

Now: Neutral

Wolfe Research

upgrade

Previous: Not converted

2024-08-08

Now: Peer Perform

Wells Fargo

downgrade

Previous: Equal-Weight

2024-08-07

Now: Underweight

JMP Securities

downgrade

Previous: Perform

2024-08-07

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.62
vs -0.87

Q4.22

arrow
arrow

N/A

-0.54
vs -0.86

Q1.23

arrow
arrow

N/A

-0.98
vs -0.98

Q2.23

arrow
arrow

N/A

-0.69
vs -0.71

Q3.23

arrow
arrow

N/A

-0.65
vs -0.62

Q4.23

arrow
arrow

N/A

-0.15
vs -0.54

Q1.24

arrow
arrow

N/A

-0.70
vs -0.98

Q2.24

arrow
arrow

N/A

-0.43
vs -0.69

Q3.24

arrow
arrow

N/A

-0.82
vs -0.65

Q4.24

arrow
arrow

N/A

-0.69
vs -0.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+8%

100.5M  vs 93.2M

Q4.22

arrow
arrow

+11%

113.8M  vs 102.8M

Q1.23

arrow
arrow

+10%

96.3M  vs 87.8M

Q2.23

arrow
arrow

+4%

108.8M  vs 104.2M

Q3.23

arrow
arrow

+3%

103.9M  vs 100.5M

Q4.23

arrow
arrow

+2%

116.2M  vs 113.8M

Q1.24

arrow
arrow

+6%

101.9M  vs 96.3M

Q2.24

arrow
arrow

-4%

104.2M  vs 108.8M

Q3.24

arrow
arrow

-10%

93.1M  vs 103.9M

Q4.24

arrow
arrow

-11%

103.4M  vs 116.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+25%

0.25
vs -0.11

Q4.22

arrow
arrow

-6%

-0.06
vs 0.25

Q1.23

arrow
arrow

-12%

-0.12
vs -0.06

Q2.23

arrow
arrow

-8%

-0.08
vs -0.12

Q3.23

arrow
arrow

-8%

-0.08
vs -0.08

Q4.23

arrow
arrow

-3%

-0.03
vs -0.08

Q1.24

arrow
arrow

-9%

-0.09
vs -0.03

Q2.24

arrow
arrow

-7%

-0.07
vs -0.09

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

192

192
vs 187

3%

Q4.22

arrow
arrow

178

178
vs 192

-7%

Q1.23

arrow
arrow

168

168
vs 178

-6%

Q2.23

arrow
arrow

161

161
vs 168

-4%

Q3.23

arrow
arrow

143

143
vs 161

-11%

Q4.23

arrow
arrow

157

157
vs 143

10%

Q1.24

arrow
arrow

165

165
vs 157

5%

Q2.24

arrow
arrow

159

159
vs 165

-4%

Earnings Growth

Latest News